Lindenwold Advisors’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,592
Closed -$242K 114
2025
Q2
$242K Sell
2,592
-89
-3% -$8.43K 0.13% 95
2025
Q1
$283K Sell
2,681
-465
-15% -$48K 0.16% 84
2024
Q4
$304K Buy
3,146
+10
+0.3% +$997 0.16% 93
2024
Q3
$310K Buy
3,136
+10
+0.3% +$915 0.16% 94
2024
Q2
$269K Hold
3,126
0.14% 93
2024
Q1
$237K Buy
3,126
+10
+0.3% +$772 0.13% 108
2023
Q4
$237K Hold
3,116
0.13% 107
2023
Q3
$215K Buy
3,116
+60
+2% +$4.32K 0.13% 104
2023
Q2
$256K Sell
3,056
-155
-5% -$12.6K 0.16% 96
2023
Q1
$237K Sell
3,211
-15
-0.5% -$1.05K 0.15% 104
2022
Q4
$228K Buy
+3,226
New +$215K 0.15% 104
2022
Q2
Sell
-3,836
Closed -$255K 116
2022
Q1
$255K Buy
3,836
+200
+6% +$12K 0.16% 102
2021
Q4
$227K Buy
+3,636
New +$244K 0.13% 121

Other funds holding MMSI

Lindenwold Advisors's MMSI Position: Q3 2025 in Review

Lindenwold Advisors sold out of Merit Medical Systems (MMSI) in Q3 2025, closing a stake of 2,592 shares — an estimated $242K sold.

Lindenwold Advisors first reported a position in MMSI in Q4 2021 and held it in 13 quarters. The position peaked at $310K in Q3 2024. 378 funds tracked by Wall St. Rank hold MMSI as of Q3 2025.

  • Lindenwold Advisors reported no remaining Merit Medical Systems position as of Q3 2025 after selling out during the quarter.
  • Lindenwold Advisors sold 2,592 Merit Medical Systems shares in Q3 2025, an estimated $242K.
  • Lindenwold Advisors first reported a position in Merit Medical Systems in Q4 2021 and held it in 13 quarters.
  • Lindenwold Advisors's Merit Medical Systems position peaked at $310K in Q3 2024.
  • 378 funds tracked by Wall St. Rank held Merit Medical Systems as of Q3 2025.

Based on Lindenwold Advisors's 13F filing for Q3 2025, filed 16 Dec 2025.